Rankings
▼
Calendar
SRPT Q1 2023 Earnings — Sarepta Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
SRPT
Sarepta Therapeutics, Inc.
$2B
Q1 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$254M
+20.2% YoY
Gross Profit
$218M
86.2% margin
Operating Income
-$138M
-54.5% margin
Net Income
-$517M
-203.8% margin
EPS (Diluted)
$-5.86
QoQ Revenue Growth
-1.9%
Cash Flow
Operating Cash Flow
-$209M
Free Cash Flow
-$219M
Stock-Based Comp.
$41M
Balance Sheet
Total Assets
$3.1B
Total Liabilities
$2.3B
Stockholders' Equity
$713M
Cash & Equivalents
$872M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$254M
$211M
+20.2%
Gross Profit
$218M
$179M
+21.8%
Operating Income
-$138M
-$87M
-58.9%
Net Income
-$517M
-$105M
-392.0%
Geographic Segments
UNITED STATES
$201M
87%
Non-US
$31M
13%
← FY 2023
All Quarters
Q2 2023 →